2005—2021年天津市医疗机构HIV/AIDS检测发现情况分析

doi:10.19485/j.cnki.issn2096-5087.2023.06.004

Preventive Medicine

2023, Vol. 35

Issue (6): 475-479 DOI: 10.19485/j.cnki.issn2096-5087.2023.06.004

Original Articles

Current Issue | Archive | Adv Search

Detection of HIV/AIDS cases in medical institutions in Tianjin Municipality from 2005 to 2021

BAI Jianyun^1,2, ZHAO Fangning¹, HOU Jinyu¹, GUO Yan¹, ZHENG Minna^1,2, LI Long^1,2, YU Maohe^1,2

1. Department of HIV/AIDS and STDs Control and Prevention, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China;
2. Tianjin Key Laboratory of Pathogenic Microbiology of Infectious Disease, Tianjin 300011, China

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (773 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the detection of HIV/AIDS cases in medical institutions in Tianjin Municipality from 2005 to 2021, so as to provide insights into optimization of HIV antibody testing strategies in medical institutions. Methods All data pertaining to individuals receiving HIV antibody tests in medical institutions in Tianjin Municipality from 2005 to 2021 were collected from the information systems in medical institutions and the HIV/AIDS Prevention and Control Information System of Chinese Disease Prevention and Control Information System. The positive rate of HIV antibody and epidemiological characteristics of HIV/AIDS cases in medical institutions were analyzed. Results The number of HIV antibody tests increased from 86 102 person-times in 2005 to 1 369 345 person-times in 2021 in medical institutions in Tianjin Municipality, with annual increase by 18.88%. The positive rate of HIV antibody increased from 2.44/10⁴ to 2.85/10⁴ (P<0.05), with annual increase by 2.79/10⁴. Both the proportion of the number of HIV antibody tests and the number of HIV/AIDS cases detected by medical institutions in the whole city appeared a tendency towards a rise (P<0.05). A high positive rate of HIV antibody was seen in sexually transmitted disease clinics (53.69/10⁴) and other testing services (12.25/10⁴), and the highest positive rate of HIV antibody was seen in individuals at ages of 20 to 39 years (5.40/10⁴), while the positive rate of HIV antibody was higher in men (5.84/10⁴) than in women (0.53/10⁴) (P<0.05). A total of 3 610 HIV/AIDS cases were detected in medical institutions in Tianjin Municipality from 2005 to 2021, with a median age of 38 (interquartile range, 24) years. Of all HIV/AIDS patients, there were 3 277 men (90.78%), and men who have sex with men was the predominant transmission route (63.46%), while the proportion of late identification of HIV/AIDS cases was 65.60%. In addition, the proportion of timely detection for the first CD4⁺T lymphocyte count testing increased from 23.81% in 2005 to 71.54% in 2021 (P<0.05). Conclusions The number of HIV antibody tests and positive rate of HIV antibody appeared a tendency towards a rise in medical institutions in Tianjin Municipality from 2005 to 2021. The HIV/AIDS cases were predominantly identified in sexually transmitted disease clinics and other testing services, and were predominantly men.

Key words： AIDS HIV antibody test medical institution

Received: 08 March 2023 Revised: 27 April 2023 Published: 13 June 2023

ZTFLH:

R512.91

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	BAI Jianyun
	ZHAO Fangning
	HOU Jinyu
	GUO Yan
	ZHENG Minna
	LI Long
	YU Maohe

Cite this article:

BAI Jianyun,ZHAO Fangning,HOU Jinyu, et al. Detection of HIV/AIDS cases in medical institutions in Tianjin Municipality from 2005 to 2021[J]. Preventive Medicine, 2023, 35(6): 475-479.

URL:

http://www.zjyfyxzz.com/EN/10.19485/j.cnki.issn2096-5087.2023.06.004 OR http://www.zjyfyxzz.com/EN/Y2023/V35/I6/475

[1] World Health Organization,Joint United Nations Programme on HIV/AIDS.Guidance on provider-initiated HIV testing and counseling in health facilities[R].Geneva:WHO,2007:18-19.
[2] World Health Organization.Consolidated guidelines on HIV prevention,testing,treatment,service delivery and monitoring:recommendations for a public health approach[M].Geneva:WHO,2021.
[3] 岳青,刘玉芬,李健,等.2009—2017年医疗机构新报告HIV感染者和艾滋病患者晚发现情况分析[J].中华预防医学杂志,2018,52(12):1248-1253.
[4] 霍俊丽,施玉华,韩瑜,等.云南省2009—2015年医疗机构PITC结果分析[J].中国艾滋病性病,2017,23(10):959-961.
[5] 何世娇,施雅莹,何勤英,等.2014—2018年成都市医疗机构HIV检测及病例发现情况分析[J].预防医学情报杂志,2019,35(12):1410-1415.
[6] 王媛媛,田飞,刘晓琳,等.东城区医疗机构艾滋病检测发现结果分析[J].预防医学,2021,33(10):1030-1032.
[7] 王瑞,张海兰,黄晓丹,等.西安市性病门诊男性就诊者艾滋病和性病监测结果[J].预防医学,2020,32(8):813-816.
[8] 王海雪,徐杰,臧春鹏.2016—2021年我国医疗机构检测发现HIV/AIDS患者情况分析[J].中国艾滋病性病,2023,29(2):157-160.
[9] 佟雪,惠珊,马静,等.黑龙江省2013—2017年医疗机构艾滋病检测情况分析[J].中国公共卫生管理,2019,35(2):269-271.
[10] 李昕,朱正平,李小杉,等.2011—2017年南京市医疗机构检测发现HIV/AIDS情况分析[J].江苏预防医学,2019,30(1):72-74.
[11] 金霞,熊然,毛宇嵘.2008—2013年我国医疗机构检测发现艾滋病病例情况分析[J].中华流行病学杂志,2015,36(4):323-326.
[12] 郑雅静. 2011—2020年天津市南开区报告HIV/AIDS病例晚发现情况分析[J].预防医学论坛,2022,28(4):274-276,280.
[13] 田志红,孙禄,刘鹏,等.2011—2017年天津市河东区艾滋病流行特征分析[J].预防医学论坛,2018,24(8):631-633,636.
[14] 王忠庆. 基于医疗大数据的临床检验医疗风险预警模型研究[D].沈阳:中国医科大学,2021.
[15] 岳青,刘玉芬,李慧,等.全国艾滋病综合防治示范区50岁及以上新报告HIV/AIDS特征及首次CD4+T淋巴细胞检测情况分析[J].中华流行病学杂志,2021,42(10):1823-1828.
[16] NOLUNDI M P,TONDERAI M,NASIPHI N,et al.Facilitators and barriers to implementing provider-initiated HIV counselling and testing at the clinic-level in Ekurhuleni District,South Africa[J/OL].Implement Sci Commun,2022,3(19)[2023-04-27].https://doi.org/10.1186/s43058-022-00269-3.
[17] EDIAS M,MORE M,GLORIAL G,et al.Evaluation of intensified provider initiated testing and counselling program in Harare City,2017-2018[J/OL].BMC Public Health,2021,21(1)[2023-04-27].https://doi.org/10.1186/s12889-021-10485-6.